Chorokbaem Healthcare Co Ltd (KO:118000) — Market Cap & Net Worth
Market Cap & Net Worth: Chorokbaem Healthcare Co Ltd (118000)
Chorokbaem Healthcare Co Ltd (KO:118000) has a market capitalization of $20.49 Million (₩30.23 Billion) as of May 22, 2026. Listed on the KO stock exchange, this Korea-based company holds position #25055 globally and #1841 in its home market, demonstrating a -15.38% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Chorokbaem Healthcare Co Ltd's stock price ₩1760.00 by its total outstanding shares 17177521 (17.18 Million). Analyse Chorokbaem Healthcare Co Ltd (118000) cash conversion ratio to see how efficiently the company converts income to cash.
Chorokbaem Healthcare Co Ltd Market Cap History: 2015 to 2026
Chorokbaem Healthcare Co Ltd's market capitalization history from 2015 to 2026. Data shows change from $41.97 Million to $20.49 Million (-5.01% CAGR).
Chorokbaem Healthcare Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Chorokbaem Healthcare Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Chorokbaem Healthcare Co Ltd's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.01x
Chorokbaem Healthcare Co Ltd's market cap is 0.01 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $126.89 Million | $11.23 Billion | -$8.62 Billion | 0.01x | N/A |
| 2017 | $40.98 Million | $36.88 Billion | -$2.91 Billion | 0.00x | N/A |
| 2018 | $24.97 Million | $34.47 Billion | -$12.04 Billion | 0.00x | N/A |
| 2019 | $41.50 Million | $56.16 Billion | -$4.80 Billion | 0.00x | N/A |
| 2020 | $29.40 Million | $26.90 Billion | $11.25 Billion | 0.00x | 0.00x |
| 2021 | $17.52 Million | $18.61 Billion | $7.74 Billion | 0.00x | 0.00x |
| 2022 | $6.05 Million | $19.10 Billion | -$49.55 Billion | 0.00x | N/A |
| 2023 | $4.66 Million | $17.26 Billion | -$14.54 Billion | 0.00x | N/A |
| 2024 | $3.28 Million | $20.21 Billion | $8.50 Billion | 0.00x | 0.00x |
| 2025 | $3.55 Million | $32.82 Billion | $498.24 Million | 0.00x | 0.01x |
Competitor Companies of 118000 by Market Capitalization
Companies near Chorokbaem Healthcare Co Ltd in the global market cap rankings as of May 22, 2026.
Key companies related to Chorokbaem Healthcare Co Ltd by market ranking:
- Eli Lilly and Company (NYSE:LLY): Ranked #15 globally with a market cap of $932.30 Billion USD.
- Eli Lilly and Company (SA:LILY34): Ranked #17 globally with a market cap of $853.51 Billion USD ( R$4.35 Trillion BRL).
- Johnson & Johnson (NYSE:JNJ): Ranked #25 globally with a market cap of $558.31 Billion USD.
- AbbVie Inc (NYSE:ABBV): Ranked #41 globally with a market cap of $356.49 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #15 | Eli Lilly and Company | NYSE:LLY | $932.30 Billion | $1041.65 |
| #17 | Eli Lilly and Company | SA:LILY34 | $853.51 Billion | R$153.70 |
| #25 | Johnson & Johnson | NYSE:JNJ | $558.31 Billion | $231.73 |
| #41 | AbbVie Inc | NYSE:ABBV | $356.49 Billion | $214.50 |
Chorokbaem Healthcare Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Chorokbaem Healthcare Co Ltd's market cap moved from $41.97 Million to $ 20.49 Million, with a yearly change of -5.01%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩20.49 Million | +477.05% |
| 2025 | ₩3.55 Million | +8.16% |
| 2024 | ₩3.28 Million | -29.50% |
| 2023 | ₩4.66 Million | -23.08% |
| 2022 | ₩6.05 Million | -65.45% |
| 2021 | ₩17.52 Million | -40.40% |
| 2020 | ₩29.40 Million | -29.17% |
| 2019 | ₩41.50 Million | +66.20% |
| 2018 | ₩24.97 Million | -39.06% |
| 2017 | ₩40.98 Million | -67.71% |
| 2016 | ₩126.89 Million | +202.36% |
| 2015 | ₩41.97 Million | -- |
End of Day Market Cap According to Different Sources
On May 22nd, 2026 the market cap of Chorokbaem Healthcare Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $20.49 Million USD |
| MoneyControl | $20.49 Million USD |
| MarketWatch | $20.49 Million USD |
| marketcap.company | $20.49 Million USD |
| Reuters | $20.49 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Chorokbaem Healthcare Co Ltd
METACARE CO., Ltd. distributes pharmaceuticals and medical devices in South Korea. The company sells orthopedic medical devices and consumables; and provides pharmaceutical integration and professional logistics services. It is involved in investment advisory. The company was formerly known as SMEDI Co., Ltd. and changed its name to METACARE CO., Ltd. in August 2024. METACARE CO., Ltd. was founde… Read more